Investment analysts at Brookline Capital Management issued their Q1 2025 earnings per share estimates for Marker Therapeutics in a report released on Monday, March 31st. Brookline Capital Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback